Forty Seven

1 Follower


Forty Seven Inc. is a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages and fight against cancer.

Aimee Murphy
VP Development Operations
Ann D. Rhoads
Chief Financial Officer
Chris H. Takimoto
Chief Medical Officer
Craig Gibbs
Chief Business Officer
Jens-Peter Volkmer
Founder and VP Research and Early Development
Kyle Elrod
SVP Planning and Operations
Mark Chao
Founder and SVP, Head of Clinical Development
Mukul Agarwal
Vice President, Corporate Development
Norman Kruse
Chief Patent Counsel
Qinghai Zhao
VP Technical Development & Manufacturing
Yasameen Qazen
VP, Regulatory Affairs and Quality Assurance

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.